Sat | Jul 31, 2021

EU proposes developing COVID-19 drug treatments

Published:Thursday | May 6, 2021 | 9:33 AM
European Union Health Commissioner Stella Kyriakides speaking during a media conference on an EU strategy on COVID-19 therapeutics at EU headquarters in Brussels, Thursday, May 6, 2021. (Kenzo Tribouillard, Pool via AP)

BRUSSELS — The European Union's executive arm has proposed EU nations join forces to develop and deploy COVID-19 treatments across the 27-nation bloc.

The European Commission says vaccines will not eradicate coronavirus “overnight” and efficient drugs will still be required to treat patients in hospitals or at home, including those with long-haul symptoms after COVID-19.

The commission wants to set up a portfolio of 10 potential COVID-19 treatments with the aim of authorising three new drugs by October to treat COVID-19.

The executive branch says two more treatments could get approved by the end of the year.

The commission says it will invest 90 million euros in studies and clinical trials and an extra 40 million euros to support manufacturing and access for COVID-19 drugs and treatments.

EU Commission President Ursula von der Leyen said this week that a quarter of all EU residents had received a first dose of coronavirus vaccine.

She says the bloc has secured enough doses to vaccinate 70% of all adults in the EU by the end of July.

Follow The Gleaner on Twitter and Instagram @JamaicaGleaner and on Facebook @GleanerJamaica. Send us a message on WhatsApp at 1-876-499-0169 or email us at onlinefeedback@gleanerjm.com or editors@gleanerjm.com.